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ABSTRACT 
The study was carried out to investigate the effect of ethanolic leaf extract of Annona muricata, ELAM on some early changes in cycas-induced colorectal 
carcinogenesis in rats. 7 groups of male Wistar rats (10 rats /group) were used. Groups were fed either mash alone or mash mixed with 5 % (w/w) cycas leaf 
powder. ELAM (100 mg/kg body weight) was administered before, simultaneously with, or after exposure to 5 % (w/w) cycas, for 30 days. After sacrifice, 
colon sections were dissected out for histological and some biochemical analysis. Results showed that cycas alone caused significant decreases in colon total 
protein (p <0.05), but administration of cycas with ELAM (irrespective of which came first) led to reversal of these decreases, with colon protein restored to 
levels higher than  values  for  controls. Cycas-induced increases in LDH  were  significantly (p <0.05) reduced by ELAM. Colon SOD,  catalase and GPx 
activities were significantly decreased in the group fed cycas, while these enzymes were significantly increased above control values in the groups fed both 
cycas and ELAM (p <0.05). In addition, the cycas-treated group had significant elevation of colon MDA, but MDA levels were significantly lowered in the 
groups fed cycas and ELAM. Histology results revealed early cancer-related morphological changes in the cycas group, including mucosal erosion, oedema 
and glandular hyperplasia. These lesions were absent in the groups given ELAM and cycas, irrespective of the duration of ELAM exposure. These results 
demonstrate evidence for protective role of ELAM in early biochemical events associated with colorectal carcinogenesis in rats. 
Keywords: Cycas, Colorectal Cancer, Annona muricata, Protection. 
 
INTRODUCTION 
Cancer is recognized as a leading cause of mortality in the 
world
1.  The  disease  affects  practically  all  tissues,  but  the 
most  prominent  forms  include  breast,  prostate,  liver  and 
colon (colorectal) cancers. These neoplasms constitute over 
50  %  of  all  newly-diagnosed  cancers  in  the  United 
Kingdom
2.  Colorectal  cancer  is  the  most  prevalent 
malignancy in the US, ranking third behind prostate and lung 
cancer in men, and behind breast and lung cancer in women
3. 
Studies have shown that colon cancer accounts for 10-50 % 
of gastro-intestinal malignancies in Nigeria
4-6. Colon cancer, 
which  begins  as  benign  polyps,  has  been  associated  with 
several  pre-disposing  factors  including  age  and  diet
7; 
inactivity  and  obesity
8;  as  well  as  sedentary  life  style
9. 
Conventional treatments for colorectal cancer are the same as 
in  other  cancers  and  include  surgery,  chemotherapy  and 
radiotherapy.  However  the  toxicity  and  side  effects 
commonly  associated  with  the  chemotherapy  and 
radiotherapy, which target all dividing cells, have tended to 
decrease survival rates of cancer patients
10. This has led to 
increasing  attention  on  alternative  remedies  with  more 
precision and minimum side effects.  Herbal remedies have 
been used for centuries as alternative to chemotherapy and 
radiotherapy
11.  Indeed  the  search  for  plant-based  cancer 
treatment strategies has continued to engage the attention of 
researchers
12.  Many  effective  anti-neoplastic  agents  have 
been isolated from plants
13. Intensive research has focused on 
the  cancer-killing  properties  of  the  leaves  and  stem  of  A. 
muricata  since  their  anti-carcinogenic  properties  became 
known
14. The anti-neoplastic agents in Annona muricata have 
been identified as acetogenins, a group of polyketide-derived 
fatty acids present in plants of the  family Annonaceae
15,16. 
Researchers at Purdue University, Indiana, have reported that 
acetogenins selectively suppress proliferation of cancer cells, 
especially  those  resistant  to  the  most  potent  chemotherapy 
drug adriamycin, without apparent toxicity to normal cells
10. 
Acetogenins  exert  their  selective  anti-neoplastic  effects  by 
inhibiting complex 1 of the mitochondrial respiratory chain, 
thereby blocking ATP supply to the cancer cells
17. Several in 
vitro  and  in  vivo  studies  have  consistently  demonstrated 
strong  anti-carcinogenic  effects  of  acetogenins  on  various 
cancers  in  experimental  animals  and  cancer  cell  lines
18-22. 
However these studies were based on pure acetogenins which 
may  not  be  readily  available  and  affordable  as  alternative 
cancer  remedies,  especially  for  the  vast  majority  of  poor 
dwellers in rural settings in the tropics, for whom the leaves 
and stem of Annona muricata offer much cheaper and more 
readily-available  options.  For  these  people,  results  from 
studies based on the crude plant extract would be  of more 
practical significance. The present study is aimed at assessing 
the  protective  effect  of  ethanolic  leaf  extract  of  Annona 
muricata  against  some  early  events  in  cycas-induced 
colorectal cancer in rats. 
 
MATERIALS AND METHODS 
Preparation of ethanolic leaf extract of Annona muricata 
(ELAM) 
A large quantity of fresh, green leaves of Annona muricata 
was collected from trees in house-hold gardens in Benin City, 
Edo State, Nigeria. The plant was identified by Dr Bamidele 
of  Department  of  Plant  Biology  and  Biotechnology, 
University of Benin and authenticated by Professor Idu of the 
same Department. A voucher specimen, number UBHa 0205 
was  deposited  at  the  Herbarium  of  Department  of  Plant Okolie Ngozi Paulinus et al: Effect of Annona muricata Linn on Cycas-induced colorectal carcinogenesis in rats 
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Biology and Biotechnology, University of Benin. The leaves 
were rinsed in tap water and dried at room temperature (about 
25
oC) for about 4 weeks. Thereafter the leaves were ground 
to fine powder in an electric blender. For extraction, 402 g of 
the powder was soaked in 2.6 liters of absolute ethanol (99 % 
w/v)  for  72  hours  with  regular  stirring.  The  extract  was 
filtered  through  sintered  funnel  and  Whatman  No.1  filter 
paper and the filtrate was concentrated in vacuo in a rotary 
evaporator. The resultant dense, greenish emulsion was dried 
in  a  beaker  under ambient air to  yield  16.3  g  of  powdery 
extract. This was kept refrigerated in a clean plastic jar prior 
to use. 
 
Collection and preparation of cycas (Cycas circinalis) leaf 
powder 
Fresh cycas leaves were collected from the Ugbowo Campus 
of  University  of  Benin.  The  leaves  were  dried  at  room 
temperature  (about  25
oC),  and  subsequently  ground  to 
powder. The powder was kept in air-tight glass jar until used. 
Strict safety procedures were adopted during the grinding and 
subsequent handling of the cycas powder, by regular use of 
nasal masks and thorough washing of hands afterwards. 
 
Experimental Animals, grouping and treatment 
70 male Wistar rats (mean weight =199 g) were randomly 
assigned to 7 groups of 10 rats each and members of each 
group housed separately in clean, disinfected cages in a room 
with a 12-hour light/dark cycle. The rats were acclimatized to 
growers  mash  (Bendel  Feed  and  Flour  Mills  Ltd,  Ewu, 
Nigeria)  for  2  weeks  prior  to  commencement  of  the 
experiment. Each group received either pure mash, or mash 
with 5 % (w/w) cycas with or without Annona muricata (100 
mg/kg  body  weight)  given  either  prior  to  or  post  cycas 
exposure.  All  groups  were  fed  their  respective  diets  for  4 
weeks.  The  groupings  and  treatments  are  summarized  in 
Table 1. 
 
Table1: Animal groups and their treatments 
 
Group  Treatment 
I (Control)  Mash  
II  Mash + 5 % (w/w) cycas 
III  Mash + 5  % (w/w)  cycas  for 3  weeks, then 100 mg 
ELAM/kg body wt. for 1 week 
IV  Mash  +  5  %  (w/w)  cycas  for  1  week,  then  100  mg 
ELAM/kg body wt. for 3 weeks 
V  Mash + 100 mg ELAM/kg body wt. for 1 week, then 5 
% (w/w) cycas for 3 weeks 
VI  Mash + 100 mg ELAM/kg body wt for 4 weeks 
VII  Mash + 5 % (w/w) cycas + 100 mg ELAM/kg body wt 
for 4 weeks 
 
The study was carried out in strict compliance with the ethics 
in  Guidelines  and  Specifications  on  Experimental  Animal 
Care
23. All groups had unrestricted access to clean drinking 
water.  The  experiment  was  conducted  at  an  average  room 
temperature of 25
oC and 12-hour day light cycle. After 30 
days,  the  rats  were  sacrificed  by  cervical  dislocation  and 
sections of the colon were dissected out, rinsed severally in 
saline  and  used  for  preparation  of  tissue  homogenates  for 
some  biochemical  assays.  Sections  for  histology  were 
immediately fixed in 10 % formol-saline prior to processing. 
The  tissue homogenate  was  prepared  by  grinding  0.5  g  of 
colon in a mortar with acid-washed sand and 5 ml of normal 
saline  for  10  minutes  at  room  temperature  (25
oC).  The 
homogenate was centrifuged at 10,000 g for 5 minutes and 
the resultant supernatant was used for the biochemical assays.  
 
Biochemical Assays  
LDH was assayed spectrophotometrically using Randox kits, 
by monitoring NAD
+ reduction at 340 nm. SOD was assayed 
by  following  auto-oxidation  of  adrenaline  at  420  nm
24. 
Catalase assay was as described by Cohen et al
25, in which 
the rate of decomposition of hydrogen peroxide is monitored 
at 480 nm. GPx activity  was determined by measuring the 
production  of  purpurogallen  from  pyrogallol  at  420  nm
26. 
Total  protein  was  estimated  colorimetrically  using  Randox 
Biuret test kits. MDA levels were measured in a colorimetric 
reaction  with  thiobarbituric  acid  as  described  by  Varshney 
and Kale
27. 
 
Histology 
Colon sections fixed in formol-saline were processed for light 
microscopy at the Department of Anatomy, Faculty of Basic 
Medical Sciences, College of Medicine, University of Benin. 
The slides were read and interpreted by one of us, G.I.E, a 
Consultant Pathologist. 
 
Statistics 
Results from biochemical assays were expressed as Mean ± 
S.E.M. Data were analyzed by paired sample Student’s t-test 
using SPSS package (version 15). Values of p < 0.05 were 
taken as significant. 
 
RESULTS 
Results for colon total protein and LDH activities for rats in 
the  various  groups  are  shown  on  Table  2.  Group  II  given 
cycas  alone  had  significantly  higher  colon  LDH  activity 
(p<0.01) and significantly lower colon total protein (p< 0.05) 
than  in  any  other  group.  1  week  treatment  with  ELAM 
following prior exposure of the rats to cycas for three weeks 
significantly  reduced  colon  LDH  below  control  levels  and 
increased  total  protein  significantly  above  control  values 
(p<0.05). A similar pattern was seen in rats given cycas for 1 
week before exposure to ELAM for 3 weeks and also in those 
exposed simultaneously to both cycas and ELAM.  
 
Table 2: Changes in colon LDH (U/100g fresh weight) and total protein 
(mg/g fresh weight) of rats in the various groups 
 
Groups  LDH  Total protein 
I  12.30 ± 1.80
a  0.443 ± 0.01
a 
II  94.81 ± 10.20
b  0.416 ± 0.10
b 
III  18.83 ± 3.10
ac  0.433 ± 0.10
ab 
IV  21.69 ± 0.60
c  0.535 ± 0.20
c 
V  4.92 ± 0.01
d  0.544 ± 0.10
c 
VI  4.43 ± 1.40
de  0.551 ± 0.01
cd 
VII  3.44 ± 0.80d
ef  0.515 ± 0.12
ce 
Values are Mean ± S.E.M. (n=10). Values having different superscripts 
between groups differ significantly (p< 0.05). 
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Table 3: Colon MDA levels, and activities of SOD, Catalase and GPx of rats in the various groups 
 
Group  MDA×10
-3 (mmoles/g fresh weight)  SOD (U/g fresh weight)  Catalase (U/g fresh weight)  GPx (U/mg fresh weight) 
I  14.73 ± 0.30
a  2.11 ± 0.010
a  321.00 ± 6.00
a  56.90 ± 4.00
a 
II  74.22 ± 0.30
b  1.71 ± 0.003
b  256.00 ± 6.00
b  37.60 ± 2.00
b 
III  53.54 ± 0.90
c  3.13 ± 0.030
c  363.00 ± 7.00
c  59.50 ± 7.00
a 
IV  33.26 ± 1.70
d  3.14 ± 0.004
cd  350.00 ± 9.00
acf  184.00 ± 2.00
c 
V  48.16 ± 1.40
e  3.00 ± 0.001
e  341.00 ± 10.00
acfg  131.00 ± 2.00
d 
VI  48.99 ± 0.60
ef  3.14 ± 0.040
cdf  367.00 ± 4.00
acfh  119.00 ± 7.00
de 
VII  40.12 ± 0.22
g  3.00 ± 0.001
eg  363.00 ± 10.00
acfgh  85.00 ± 4.00
ef 
Values are represented as Mean ±S .E.M. (n=10). For each parameter, values having different superscripts between groups differ significantly (p< 0.05). 
 
Figures 1 to 7 are photomicrographs of colon sections taken from rats in most of the groups investigated, depicting either pathological changes or 
normal colon architecture, as indicated. 
 
 
 
 
Figure 1: Rat colon from control group showing normal mucosal lining A, glands B and muscularis mucosa C (H and E; x 10) 
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Figure 2 : Colon section of rats treated with cycas for 4 weeks, showing mucosal erosion (A); oedema (B) and glandular hyperplasia (C). (H and E; x 
10) 
 
     
 
 
Figure 3: Rat colon treated with cycas for 3 weeks and Annona muricata for 1 week showing reduced mucosal damage A and reduced 
glandular abnormality B (H and E; x 10) 
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Figure 4: Rat colon treated with cycas for 1 week and Annona muricata for 3 weeks showing marked reduction in the mucosal damage A 
and in the glandular abnormality B (H and E; x 10) 
 
 
 
Figure 5: Colon section from rats treated with Annona muricata for 1 week followed by cycas for 3 weeks. Mucosal oedema A, abnormal 
mitosis B and mild infiltrates of chronic inflammatory cells C are shown (H and E; x 40) 
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Figure 6: Section of colon from rats treated with Annona muricata for 4 weeks showing fairly unremarkable mucosal lining A, glands B 
and mildly activated lymphoid aggregates C (H and E; x 10) 
 
 
 
Figure 7: Colon section of rats treated simultaneously with Annona muricata and cycas for 4 weeks. Fairly unremarkable mucosal lining A 
and glands B are seen (H and E; x 10) 
 
DISCUSSION 
Extracts  of  medicinal  plants  have  been  employed  for 
centuries  in  the  treatment  of  a  variety  of  diseases.  Indeed 
cancer  is  one  of  the  diseases  for  which  intensive  research 
towards a plant-based treatment is on-going
12. The quest for 
herbal  remedy  for  cancer  is  informed  by  the  toxic  side 
effects,  lack  of  specificity  and  resistance  associated  with 
conventional  chemotherapeutic  strategies
10.  In  the  present 
study,  the  abnormal  changes  seen  in  the  colon 
photomicrographs of the rats given cycas alone (i.e. mucosal 
erosion,  oedema  and  glandular  hyperplasia)  are  consistent 
with  early  events  in  cycas-induced  carcinogenesis.  Cycas 
A 
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(Cycas circinalis) contains cycasin and its aglycone methyl 
azoxymethanol, which are known to induce colon cancer in 
lower  animals
28.  On  ingestion  of  a  cycas  meal,  intestinal 
bacteria hydrolyse the ß-glucoside bond of cycasin to release 
the  aglycone,  methyl  azoxymethanol
28.  Since  researchers 
became  aware  of  the  potent  carcinogenic  properties  of 
cycasin and methyl azoxymethanol, these agents have been 
employed as reliable animal models for inducing a range of 
intestinal  cancers,  including  colorectal  cancer
29,30.  Due  to 
increased  energy  demand  and  mitochondrial  dysfunction, 
cancer  cells  are  known  to  exhibit high rates  of  glycolysis, 
even  under  aerobic  conditions
31,32.  It  is  now  known  that 
succinate, an intermediate of tricarboxylic acid cycle, serves 
as  the  link  between  mitochondrial  dysfunction  and 
oncogenesis  via  hypoxia-inducible  factor,  HIF-1α
33. 
Mitochondrial dysfunction in turn leads to accumulation of 
the glycolytic intermediate pyruvate and elevated activities of 
LDH through substrate-activation of LDH gene
31. This is in 
agreement with the significant increases in colon LDH seen 
in  the  rats  given  cycas  alone,  which  is  a  manifestation  of 
some  early  events  in  carcinogenesis.  These  very  high 
increases in colon LDH were significantly reduced to control 
values by administration of ELAM after 3 weeks  of cycas 
exposure,  with  significant  reduction  in  the  accompanying 
pathological  changes  i.e.  reduced  mucosal  damage  and 
reduced  glandular  abnormality.  This  demonstrates  a 
protective  role  of  Annona  muricata  in  cycas-induced 
carcinogenesis.  Further  evidence  is  seen  in  the  Annona 
muricata-mediated  reversal  of  decreases  in  colon  tissue 
protein, anti-oxidant enzymes (catalase, GPx and SOD); and 
the  reduction  in  MDA  levels  (lipid  peroxidation).  Lipid 
peroxidation  is  an  important  pre-disposing  factor  in 
carcinogenesis
34. The pattern of changes in the levels of the 
antioxidant enzymes, as well as LDH and MDA also indicate 
that  co-administration  of  ELAM  and  cycas  neutralizes  the 
deleterious  effect  of  cycas.  This  is  corroborated  by 
histological  evidence  of  near-normal  or  completely  normal 
colon  architecture  in  the  groups  given  cycas  and  Annona 
muricata extract simultaneously and in the group given cycas 
for one week prior to a 3-week exposure to cycas. The cycas-
induced decrease in colon protein is in agreement with tissue 
protein  loss  usually  associated  with  most  cancers  and  the 
ability of Annona muricata to reverse it is a further indication 
of its protective effect. Weight loss, which is an important 
prognostic factor in cancer
36; has been attributed to increased 
protein  degradation  and/or  decreased  protein  synthesis
37,38. 
The  observed  protective  effect  of  Annona  muricata in  this 
study can be attributed to annonaceous acetogenins present in 
the plant
15,16. Acetogenins destroy cancer cells by blocking 
NADH-CoQ  oxidoreductase  (complex  1),  thereby  starving 
the  cancer  cells  of  much-needed  ATP
17.  Annonaceous 
acetogenins  also  possess  potent  anti-oxidant  properties
39. 
This  may  in  part  account  for  the  observed  significant 
decreases in lipid peroxidation in the rats exposed to Annona 
muricata  and  the  significantly  enhanced  anti-oxidant 
potential of these groups relative to those exposed to cycas 
alone. Although data from several in vitro and in vivo studies 
have  confirmed  the  potent  anti-neoplastic  properties  of 
annonaceous acetogenins, the absence of direct information 
from human studies have tended to play down the therapeutic 
import of these findings.  
 
 
 
CONCLUSION 
The results obtained in this study demonstrate evidence for a 
protective role of  ethanolic extract of Annona muricata on 
some early events associated with colorectal carcinogenesis 
in rats. Since the properties of intact biological systems are 
often more than the sum of properties of purified individual 
components,  the  use  of  crude  leaf  extracts  of  Annona 
muricata may indeed be more beneficial than the application 
of purified acetogenins. If animal-to-human extrapolation is 
permitted, our results indicate a promising potential for the 
use  of  leaves  of  Annona  muricata  in  the  management  of 
colorectal cancer. This is considered beneficial and of more 
practical  significance  where  commercial  preparations  of 
acetogenins are not readily available or affordable, especially 
in  poor,  rural  communities  with  unrestricted  access  to  the 
plant in its natural form. 
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